Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 110

1.

Phase I and biomarker study of plerixafor and bevacizumab in recurrent high-grade glioma.

Lee EQ, Duda DG, Muzikansky A, Gerstner E, Kuhn JG, Reardon DA, Nayak L, Norden AD, Doherty L, LaFrankie D, Stefanik J, Vardam T, Smith KH, McCluskey C, Gaffey SC, Batchelor T, Jain RK, Wen PY.

Clin Cancer Res. 2018 Jun 25. pii: clincanres.1025.2018. doi: 10.1158/1078-0432.CCR-18-1025. [Epub ahead of print]

PMID:
29941486
2.

Daratumumab at the frontiers of post-transplant refractory T-acute lymphoblastic leukemia-a worthwhile strategy?

Bonda A, Punatar S, Gokarn A, Mohite A, Shanmugam K, Nayak L, Bopanna M, Cheriyalinkal Parambil B, Khattry N.

Bone Marrow Transplant. 2018 Jun 8. doi: 10.1038/s41409-018-0222-5. [Epub ahead of print] No abstract available.

PMID:
29884853
3.

Working plan for the use of patient-reported outcome measures in adults with brain tumours: a Response Assessment in Neuro-Oncology (RANO) initiative.

Dirven L, Armstrong TS, Blakeley JO, Brown PD, Grant R, Jalali R, Leeper H, Mendoza T, Nayak L, Reijneveld JC, Le Rhun E, Walbert T, Weller M, Wen PY, Taphoorn MJB.

Lancet Oncol. 2018 Mar;19(3):e173-e180. doi: 10.1016/S1470-2045(18)30004-4. Review.

PMID:
29508764
4.

Factor XII and uPAR upregulate neutrophil functions to influence wound healing.

Stavrou EX, Fang C, Bane KL, Long AT, Naudin C, Kucukal E, Gandhi A, Brett-Morris A, Mumaw MM, Izadmehr S, Merkulova A, Reynolds CC, Alhalabi O, Nayak L, Yu WM, Qu CK, Meyerson HJ, Dubyak GR, Gurkan UA, Nieman MT, Sen Gupta A, Renné T, Schmaier AH.

J Clin Invest. 2018 Mar 1;128(3):944-959. doi: 10.1172/JCI92880. Epub 2018 Jan 29.

5.

Uremic Advanced Glycation End Products and Protein-Bound Solutes Induce Endothelial Dysfunction Through Suppression of Krüppel-Like Factor 2.

Saum K, Campos B, Celdran-Bonafonte D, Nayak L, Sangwung P, Thakar C, Roy-Chaudhury P, Owens AP Iii PhD.

J Am Heart Assoc. 2018 Jan 4;7(1). pii: e007566. doi: 10.1161/JAHA.117.007566.

6.

Kruppel-like factor 4 regulates neutrophil activation.

Shen Y, Hong H, Sangwung P, Lapping S, Nayak L, Zhang L, Jain MK, Liao X.

Blood Adv. 2017 Apr 20;1(11):662-668. doi: 10.1182/bloodadvances.2017004341. eCollection 2017 Apr 25.

7.

High-grade Gliomas.

Nayak L, Reardon DA.

Continuum (Minneap Minn). 2017 Dec;23(6, Neuro-oncology):1548-1563. doi: 10.1212/CON.0000000000000554.

PMID:
29200110
8.

Retrospective analysis of palliative metronomic chemotherapy in head and neck cancer.

Patil VM, Noronha V, Joshi A, Nayak L, Pande N, Chandrashekharan A, Dhumal S, Bhattacharjee A, Banavali S, Prabhash K.

Indian J Cancer. 2017 Jan-Mar;54(1):25-29. doi: 10.4103/ijc.IJC_161_17.

9.

Salvage re-irradiation for recurrent high-grade glioma and comparison to bevacizumab alone.

Arvold ND, Shi DD, Aizer AA, Norden AD, Reardon DA, Lee EQ, Nayak L, Dunn IF, Golby AJ, Johnson MD, Claus EB, Chiocca EA, Ligon KL, Wen PY, Alexander BM.

J Neurooncol. 2017 Dec;135(3):581-591. doi: 10.1007/s11060-017-2611-9. Epub 2017 Oct 3.

PMID:
28975467
10.

1,3-Dipolar Cycloaddition Reactions for the Synthesis of Novel Oxindole Derivatives and Their Cytotoxic Properties.

Mali PR, Shirsat PK, Khomane N, Nayak L, Nanubolu JB, Meshram HM.

ACS Comb Sci. 2017 Oct 9;19(10):633-639. doi: 10.1021/acscombsci.7b00044. Epub 2017 Sep 7.

PMID:
28816439
11.

The Neurologic Assessment in Neuro-Oncology (NANO) scale: a tool to assess neurologic function for integration into the Response Assessment in Neuro-Oncology (RANO) criteria.

Nayak L, DeAngelis LM, Brandes AA, Peereboom DM, Galanis E, Lin NU, Soffietti R, Macdonald DR, Chamberlain M, Perry J, Jaeckle K, Mehta M, Stupp R, Muzikansky A, Pentsova E, Cloughesy T, Iwamoto FM, Tonn JC, Vogelbaum MA, Wen PY, van den Bent MJ, Reardon DA.

Neuro Oncol. 2017 May 1;19(5):625-635. doi: 10.1093/neuonc/nox029. Review.

12.

High-dose chemotherapy with thiotepa, busulfan, and cyclophosphamide and autologous stem cell transplantation for patients with primary central nervous system lymphoma in first complete remission.

DeFilipp Z, Li S, El-Jawahri A, Armand P, Nayak L, Wang N, Batchelor TT, Chen YB.

Cancer. 2017 Aug 15;123(16):3073-3079. doi: 10.1002/cncr.30695. Epub 2017 Apr 3.

PMID:
28369839
13.

PD-1 blockade with nivolumab in relapsed/refractory primary central nervous system and testicular lymphoma.

Nayak L, Iwamoto FM, LaCasce A, Mukundan S, Roemer MGM, Chapuy B, Armand P, Rodig SJ, Shipp MA.

Blood. 2017 Jun 8;129(23):3071-3073. doi: 10.1182/blood-2017-01-764209. Epub 2017 Mar 29.

14.

Krüppel-like factors in endothelial cell biology.

Chang E, Nayak L, Jain MK.

Curr Opin Hematol. 2017 May;24(3):224-229. doi: 10.1097/MOH.0000000000000337. Review.

PMID:
28306664
15.

KLF2 and KLF4 control endothelial identity and vascular integrity.

Sangwung P, Zhou G, Nayak L, Chan ER, Kumar S, Kang DW, Zhang R, Liao X, Lu Y, Sugi K, Fujioka H, Shi H, Lapping SD, Ghosh CC, Higgins SJ, Parikh SM, Jo H, Jain MK.

JCI Insight. 2017 Feb 23;2(4):e91700. doi: 10.1172/jci.insight.91700.

16.

Phase I trial of aflibercept (VEGF trap) with radiation therapy and concomitant and adjuvant temozolomide in patients with high-grade gliomas.

Nayak L, de Groot J, Wefel JS, Cloughesy TF, Lieberman F, Chang SM, Omuro A, Drappatz J, Batchelor TT, DeAngelis LM, Gilbert MR, Aldape KD, Yung AW, Fisher J, Ye X, Chen A, Grossman S, Prados M, Wen PY.

J Neurooncol. 2017 Mar;132(1):181-188. doi: 10.1007/s11060-016-2357-9. Epub 2017 Jan 23.

17.

Viral Agents Causing Acute Respiratory Infections in Children under Five: A Study from Eastern India.

Mishra P, Nayak L, Das RR, Dwibedi B, Singh A.

Int J Pediatr. 2016;2016:7235482. doi: 10.1155/2016/7235482. Epub 2016 Nov 27.

18.

Precision medicine with electronic medical records: from the patients and for the patients.

Nayak L, Ray I, De RK.

Ann Transl Med. 2016 Oct;4(Suppl 1):S61. No abstract available.

19.

ALK Positive Lung Cancer: Clinical Profile, Practice and Outcomes in a Developing Country.

Noronha V, Ramaswamy A, Patil VM, Joshi A, Chougule A, Kane S, Kumar R, Sahu A, Doshi V, Nayak L, Mahajan A, Janu A, Prabhash K.

PLoS One. 2016 Sep 16;11(9):e0160752. doi: 10.1371/journal.pone.0160752. eCollection 2016. Erratum in: PLoS One. 2016 Dec 9;11(12 ):e0168221.

20.

Wnt signal transduction pathways: modules, development and evolution.

Nayak L, Bhattacharyya NP, De RK.

BMC Syst Biol. 2016 Aug 1;10 Suppl 2:44. doi: 10.1186/s12918-016-0299-7.

Supplemental Content

Loading ...
Support Center